NeuroPace (NPCE) Change in Accured Expenses (2020 - 2026)

NeuroPace has reported Change in Accured Expenses for 7 years, with the latest figure at $1.5 million in Q2 2026.

• On a quarterly basis, Change in Accured Expenses fell 31.95% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $1.2 million, a 38.51% decrease from a year earlier, with the FY2025 full-year figure at $3.6 million, up 355.17% from the prior year.
• Change in Accured Expenses was $1.5 million for Q2 2026 at NeuroPace, up from -$4.0 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $2.6 million in Q3 2025, with the low at -$4.0 million in Q1 2026.
• Average Change in Accured Expenses over 5 years is $190222.2, with a median of $521500.0 recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses surged 39975.0% in 2023, then tumbled 366.43% in 2024.
• Over 5 years, Change in Accured Expenses stood at -$136000.0 in 2022, then jumped by 941.91% to $1.1 million in 2023, then plunged by 124.8% to -$284000.0 in 2024, then soared by 459.86% to $1.0 million in 2025, then surged by 47.36% to $1.5 million in 2026.
• The last three Change in Accured Expenses figures came in at $1.5 million (Q2 2026), -$4.0 million (Q1 2026), and $1.0 million (Q4 2025), per Business Quant data.